News Hub
The latest breaking stories
Access up-to-date news and information on a wide range of press releases including business, finance, technology, healthcare, entertainment, and more.
Discover the most important & comprehensive stories delivered directly to you daily.
- Education Training
- 07/02/2025
- 13:46
Back-to-School Made Easy: Reset Moves CEO Shares Expert Tips for a Smooth Transition
As the festive season wraps up and children across Australia gear up for a return to school after a long break, many parents are…
- Contains:
- Banking
- 07/02/2025
- 13:11
Circulate Capital Strengthens Indonesia Commitment With the Appointment of Dondi Hananto as Associate Investment Partner, SEA, and Head of Indonesia
SINGAPORE, SG / ACCESS Newswire / February 6, 2025 / Circulate Capital, a leading circular economy investment management firm in high-growth markets, has appointed Dondi Hananto as Associate Investment Partner, Southeast Asia, and Head of Indonesia. This strategic appointment reinforces Circulate Capital's commitment to strengthening its commitment to investing in in Indonesia, a key market for scaling plastic recycling and waste management solutions.Since its launch in December 2019, backed by leading global corporations, Circulate Capital has built the largest investment portfolio of companies in South and Southeast Asia dedicated to fighting plastic pollution. This includes three impactful debt and equity…
- Biotechnology
- 07/02/2025
- 12:57
OncoSil Medical (ASX:OSL) Investor Webinar Invitation
Sydney, Australia – 7 February 2025: Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) will host an investor webinar on Tuesday 11 February 2025. The webinar will be presented by OncoSil’s Chief Executive Officer & Managing Director, Nigel Lange, and will be followed by a short Q&A session. In his webinar presentation, Mr Lange will discuss recent developments in the OncoSil™ device’s commercialisation strategy, including: An update on the German Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) approval for the Directive for testing the new treatment method: "Endoscopic injection-implantation of 32Plabeled microparticles in unresectable, locally advanced pancreatic tumors." The authorisation…
- Animal Animal WelfareRights, Environment
- 07/02/2025
- 12:53
Is rainfall a source of PFAS chemicals in Sydney drinking water reservoirs?
Early this weekFriends of the Earth received two GIPA requests from WaterNSW and Sydney Water. The information FoE requested concerned detections of all PFAS chemicals through their drinking water supplies. Over the past 6 months,WaterNSWandSydney Waterhave conducted hundreds of PFAS tests and have published online PFAS results pertaining only to those listed under the Australian Drinking Water Guidelines, namely PFOS, PFHxS and PFOA. Sydney Water however screen for a total of 45 PFAS chemicals, with WaterNSW screening for 30. FoE was interested in what other PFAS chemicals were being detected. Information gathered from theGIPA requests was presented to Select Committee…
- Technology Innovation
- 07/02/2025
- 12:11
Ant International appoints Chief Innovation Officer to Spearhead AI-Driven Digitalisation Strategy with new Product, Technology and Innovation Framework
Jiang-Ming Yang will be responsible for driving investments in and synergy between product and technology teams A new CIO Organisation will be created to…
- Contains:
- Biotechnology, Business Company News
- 07/02/2025
- 11:52
AdAlta (ASX:1AD) investor webinar invitation: “East to West” cellular immunotherapy strategy
The webinar will be presented by AdAlta’s Chief Executive Officer & Managing Director, Dr Tim Oldham, and will be followed by a short Q&A session In his webinar presentation, DrOldham will discuss the results of AdAlta’s strategic review and portfolio prioritization announced separately today, including: • What drives AdAlta’s “East to West” cellular immunotherapy strategy• How the “East to West” strategy will be AdAlta’s key driver of future pipeline growth and value creation• Recent progress made in executing the “East to West” strategy, including the signing of term sheets• How the value inherent in AdAlta’s fibrosis disease drug candidate AD-214…
- Environment
- 07/02/2025
- 11:45
EPA CALLING FOR COMMUNITY HELP ON POISONED MAGPIES
The NSW Environment Protection Authority (EPA) is appealing for information from the Bonny Hills community after what it suspects may have been the deliberate poisoning of magpies in the area. In November last year, the EPA received a report that at least 12 magpies were found sick or deceased by members of the public and the wildlife group, For Australian Wildlife Needing Aid (FAWNA). EPA Director Operations, John Forcier, said toxicological testing of the birds has ruled out avian influenza, however toxic levels of pesticides were present, suggesting the poisoning may have been deliberate. “Several chemicals were identified, including Deltamethrin…
- Technology Innovation
- 07/02/2025
- 11:12
The Most Anticipated AI Chatbot Revolution | Yep AI Launches Digital Human in 2025
MELBOURNE–BUSINESS WIRE– Yep AI, a pioneering AI solutions company, has announced the launch of its latest innovation, the Yep AI Digital Human, set to…
- Contains:
- Medical Health Aged Care
- 07/02/2025
- 10:35
Memory Walk & Jog Canberra is just weeks away!
The 2025 Canberra Memory Walk & Jog is just a few short weeks away, with the event taking place on Sunday, 23 February at Barrine Drive, Lake Burley Griffin. Following overwhelming support for last year's Canberra Memory Walk & Jog, we are returning bigger and better for another year. Memory Walk & Jog Canberra will help advance the work of Dementia Australia, which delivers invaluable support, education and resources for people living with dementia, their families and carers. Memory Walk & Jog is about being part of the community and feeling supported. We are in this together, which is why…
- Contains:
Media Outreach made fast, easy, simple.
Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.